Regen BioPharma Inc Sustainability Reports
Regen BioPharma Inc. focuses on the immunology and immunotherapy space, primarily developing small molecule therapies for treating cancer and autoimmune disorders.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300S6GNPDQ0F5FT79
FIGI: BBG005D7QPQ6
No reports are currently available in our catalogue.